A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
- 14 November 2001
- journal article
- clinical trial
- Published by Wiley in European Journal of Neurology
- Vol. 8 (6) , 559-565
- https://doi.org/10.1046/j.1468-1331.2001.00277.x
Abstract
Objective. To study the efficacy and safety of botulinum toxin type A (BtxA) in the treatment of upper limb muscle spasticity, caused by stroke. Methods. This was a randomized, controlled trial. Pa...Keywords
This publication has 14 references indexed in Scilit:
- Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trialJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Use of botulinum toxin in stroke patients with severe upper limb spasticity.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Botulinum toxin type A in the treatment of upper extremity spasticityNeurology, 1996
- The effectiveness of chemical neurolysis in the treatment of lower limb muscle spasticityClinical Rehabilitation, 1996
- Assessment [RETIRED]Neurology, 1990
- Botulinum toxin injections for cervical dystoniaNeurology, 1990
- Effect of treatment with botulinum toxin on spasticityPostgraduate Medical Journal, 1989
- The Barthel ADL Index: A reliability studyInternational Disability Studies, 1988
- Recovery after stroke--the first 3 months.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Impairment of voluntary movement by spasticityAnnals of Neurology, 1979